blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2062585

EP2062585 - THE ANTIBIOTICS COMPOSITION COMPRISING AMINOGLYCOSIDE ANTIBIOTICS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.06.2014
Database last updated on 19.10.2024
Most recent event   Tooltip27.06.2014Application deemed to be withdrawnpublished on 30.07.2014  [2014/31]
Applicant(s)For all designated states
Tianjin Hemay Bio-Tech Co., Ltd
Xiao Yuan Xin Cun
31-101 Teda
Tianjin 300457 / CN
[N/P]
Former [2010/26]For all designated states
Tianjin Hemay Bio-Tech Co., Ltd.
Xiao Yuan Xin Cun 31-101 Teda
Tianjin 300457 / CN
Former [2009/22]For all designated states
Tianjin Hemey Bio-Tech Co., Ltd.
Xiao Yuan Xin Cun, 31-101 Teda
Tianjin 300457 / CN
Inventor(s)01 / ZHANG, Hesheng
Xiao Yuan Xin Cun 31-101 TEDA
Tianjin 300457 / CN
 [2009/22]
Representative(s)Hryszkiewicz, Danuta, et al
Kancelaria Patentowa
Matthias Scholl, Inc.
Skrytka Pocztowa 13
75-454 Koszalin / PL
[N/P]
Former [2009/22]Hryszkiewicz, Danuta, et al
Kancelaria Patentowa ul. Jana z Kolna 38
PL-75-204 Koszalin / PL
Application number, filing date07785340.614.08.2007
[2009/22]
WO2007CN02440
Priority number, dateCN2006101543925.08.2006         Original published format: CN200610015439
[2009/22]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008025227
Date:06.03.2008
Language:ZH
[2008/10]
Type: A1 Application with search report 
No.:EP2062585
Date:27.05.2009
Language:EN
[2009/22]
Search report(s)International search report - published on:CN06.03.2008
(Supplementary) European search report - dispatched on:EP23.10.2009
ClassificationIPC:A61K31/7036, A61K47/18, A61K47/12, A61K47/02, A61K47/04, A61K9/08, A61K9/19, A61P31/04, A61P31/00
[2009/22]
CPC:
A61K31/7036 (EP,US); A61K31/43 (EP,US); A61K31/545 (EP,US);
A61K9/0019 (EP,US); A61K9/19 (EP,US); A61P31/00 (EP);
A61P31/04 (EP); A61P43/00 (EP); A61K47/12 (EP,US);
A61K47/183 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/22]
TitleGerman:ANTIBIOTISCHE ZUSAMMENSETZUNG MIT AMINOGLYKOSID-ANTIBIOTIKA[2009/22]
English:THE ANTIBIOTICS COMPOSITION COMPRISING AMINOGLYCOSIDE ANTIBIOTICS[2009/22]
French:COMPOSITION ANTIBIOTIQUE COMPRENANT DES ANTIBIOTIQUES AMINOGLYCOSIDES[2009/22]
Entry into regional phase25.03.2009Translation filed 
25.03.2009National basic fee paid 
25.03.2009Search fee paid 
25.03.2009Designation fee(s) paid 
25.03.2009Examination fee paid 
Examination procedure25.03.2009Examination requested  [2009/22]
06.11.2009Despatch of a communication from the examining division (Time limit: M06)
10.05.2010Reply to a communication from the examining division
16.08.2010Despatch of a communication from the examining division (Time limit: M06)
28.02.2011Reply to a communication from the examining division
06.05.2011Despatch of a communication from the examining division (Time limit: M04)
14.09.2011Reply to a communication from the examining division
12.01.2012Despatch of a communication from the examining division (Time limit: M04)
03.05.2012Reply to a communication from the examining division
10.07.2012Despatch of a communication from the examining division (Time limit: M04)
08.11.2012Reply to a communication from the examining division
02.01.2014Communication of intention to grant the patent
01.03.2014Application deemed to be withdrawn, date of legal effect  [2014/31]
25.03.2014Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/31]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.11.2009
Fees paidRenewal fee
25.03.2009Renewal fee patent year 03
27.08.2010Renewal fee patent year 04
26.08.2011Renewal fee patent year 05
21.08.2012Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.08.201307   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]EP1468697  (WYETH CORP [US]) [X] 1-9 * table 1; [0079]-[0089] * [Y] 1-10;
 [Y]WO2006085337  (VENUS REMEDIES LTD [IN], et al) [Y] 1-10 * page 7, line 7-19; page 10, line 33-37 *
 [XY]  - CHAUDHARY M; JOEDURY M, "Composition for treating e.g. cystic fibrosis comprises antibiotic combination for simultaneous delivery of antibiotics, where one acting in concentration-dependent manner is aminoglycosides and other in time-dependent manner is beta-lactam", WPI / Thomson, 0, Derwent World Patents Index, (20060818), vol. 2007, no. 11, Database accession no. 2007-110449, XP002542735 [X] 1-5,7 * table 2 on page 20-22; example 3 * [Y] 1-10
International search[X]CN1569010  (UNIV ZHEJIANG [CN]);
 [X]CN1813680  (WANG MIAN [CN]);
    [ ] - ZHONGGUO YAOXUE ZAZHI, (1990), vol. 25, no. 10, pages 589 - 592
 [X]  - LIU CHAOYING ET AL., "Studies on the 0.5% amikacin sulfate eye-drops", JOURNAL OF HUBEI UNIVERSITY (NATURAL SCIENCE), (199606), vol. 18, no. 2, pages 202 - 204, XP008104506
 [X]  - PING L. ET AL., "Preparation of ribostamycin sulfate injection", CHINESE MEDICINE, Database accession no. (89000170), XP008105752
    [ ] - YAOXUE TONGBAO, (1988), vol. 23, no. 4, pages 212 - 213
by applicant   - Remmington's Pharmaceutical Science, MARK PUBLISHING, (1990), page 1567
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.